Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine

Int Immunol. 2000 Mar;12(3):295-303. doi: 10.1093/intimm/12.3.295.

Abstract

Synthetic oligodeoxynucleotides containing CpG motifs [immunostimulatory sequences (ISS)] have been described as potent adjuvants of type 1 immune responses when co-administered with protein or peptide vaccines. To investigate their role in the immune response to polysaccharides (CHO), different preparations of anti-Haemophilus influenzae type b (Hib) conjugate vaccine were administered to mice. The unconjugated CHO did not induce the synthesis of specific antibodies even in the presence of ISS. On the other hand, anti-CHO-specific antibodies significantly increased in the presence of ISS, when tetanus (TT) or diphtheria [cross-reacting material (CRM)] toxoid-conjugated CHO were used to immunize mice. The adjuvant effect was also observed for the immune response against the carrier protein (TT and CRM). ISS insured an early and long-lasting specific IgG production. The effects of ISS on the anti-CHO immune response could be attributed to the amplification of the T help provided by the carrier. The analysis of anti-CHO IgG subclasses showed a significant increase of IgG2a and IgG3 in the presence of ISS. ISS caused a rapid release of IL-12 and IFN-gamma in sera from treated mice. This data provide a first evidence for the ability of ISS to induce an anti-CHO type 1-like immune response and demonstrate that ISS have the potential to increase host antibody response against both the CHO and the protein component of a conjugated vaccine.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Antibodies, Bacterial / biosynthesis*
  • Bacterial Capsules
  • CpG Islands*
  • Cytokines / metabolism
  • Diphtheria Toxoid / immunology
  • Drug Carriers
  • Female
  • Haemophilus Vaccines / immunology*
  • Immunization
  • Immunoglobulin G / biosynthesis*
  • Immunoglobulin G / immunology
  • Mice
  • Mice, Inbred BALB C
  • Oligodeoxyribonucleotides / immunology*
  • Polysaccharides, Bacterial / immunology*
  • Tetanus Toxoid / immunology
  • Th1 Cells / immunology*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Bacterial
  • Cytokines
  • Diphtheria Toxoid
  • Drug Carriers
  • Haemophilus Vaccines
  • Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate
  • Haemophilus influenzae type b polysaccharide vaccine
  • Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate
  • Immunoglobulin G
  • Oligodeoxyribonucleotides
  • Polysaccharides, Bacterial
  • Tetanus Toxoid